WEJ-57070-38602
2 vaccinations
2 coded responses
21 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 200 / DC
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-27
Registered in v-safe
-
2021-03-27
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-27
-
2021-03-28
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-30
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-02
- 2021-04-03
- 2021-04-10
- 2021-04-17
- 2021-04-24
- 2021-05-03
- 2021-05-08
- 2021-06-26
-
2021-09-26
Survey response — 6 months, dose 1MedDRA: Headache, Myalgia, Oropharyngeal pain — Feeling: Good · Be unable to work or attend schoolFree text: Muscle aches, sore throat, headachesMedDRA releases: 2024-11 · check-in free text available
-
2021-10-31
Dose 2 — Pfizer-BioNTech
-
2021-11-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-07
- 2021-11-16
- 2021-11-28
- 2021-12-14
- 2022-05-03
-
2022-10-31
Survey response — 12 months, dose 2MedDRA: Depression, Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Depression, cold symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-10-31
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-01
-
2022-11-04
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-27 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-31 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-31 | Successful 2022-11-04 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 9 — 6 months, dose 1
Symptoms: Muscle aches, sore throat, headaches
Release 12 — 12 months, dose 2
Symptoms: Depression, cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Depression | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release